WATSON 583 (Propafenone Hydrochloride 225 MG)
Pill with imprint WATSON 583 is White, Round and has been identified as Propafenone Hydrochloride 225 MG. It is supplied by Watson Laboratories, Inc..
Propafenone is used in the treatment of atrial fibrillation; atrial flutter; wolff-parkinson-white syndrome; ventricular tachycardia and belongs to the drug class group I antiarrhythmics. Risk cannot be ruled out during pregnancy. Propafenone 225 MG is not a controlled substance under the Controlled Substances Act (CSA).
Images for WATSON 583
- WATSON 583
- 225 MG
- 10.00 mm
- Prescription only
- Drug Class
- Group I antiarrhythmics
- Pregnancy Category
- C - Risk cannot be ruled out
- CSA Schedule
- Not a controlled drug
- Labeler / Supplier
- Watson Laboratories, Inc.
- Inactive Ingredients
silicon dioxide, croscarmellose sodium, crospovidone, hypromelloses, magnesium stearate, microcrystalline cellulose, polydextrose, polyethylene glycol, corn starch, sodium lauryl sulfate, titanium dioxide, triacetin
Note: Inactive ingredients may vary.
Labelers / Repackagers
|NDC Code||Labeler / Repackager|
|00591-0583||Watson Pharmaceuticals, Inc.|
|63739-0510||McKesson Packaging Services|
|54569-6133||A-S Medication Solutions, LLC (repackager)|
More about propafenone
- Side Effects
- During Pregnancy or Breastfeeding
- Dosage Information
- Drug Images
- Drug Interactions
- Pricing & Coupons
- En Español
- 57 Reviews
- Drug class: group I antiarrhythmics
- FDA Alerts (1)
- Propafenone (Advanced Reading)
- Propafenone Tablets
- Propafenone Sustained-Release Capsules
Related treatment guides
Always consult your healthcare provider to ensure the information displayed on this page applies to your personal circumstances.